SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001567619-22-016334
Filing Date
2022-08-16
Accepted
2022-08-16 08:22:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13D/A 100466
  Complete submission text file 0001567619-22-016334.txt   102045
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address 156 S. FIRST STREET ZIONSVILLE IN 46077 317-344-6689
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

IRS No.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89959 | Film No.: 221168560
SIC: 2834 Pharmaceutical Preparations